DAREON™-8: A study to test how well different doses of BI 764532 in addition to standard of care are tolerated by people with advanced small cell lung cancer

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-506008-20-00

Acronym

1438-0008

Enrollment

Registered

2023-12-06

Start date

2024-01-11

Completion date

Unknown

Last updated

2025-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extensive-stage small cell lung carcinoma (ES-SCLC)

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, France, Germany, Poland, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026